Dale McElveen is a passionate clinical operations leader with 25+ years of excellence in global clinical trial execution. Her clinical operational expertise has contributed to drug approvals by FDA and other global health authorities in Canada, Europe, Japan, and China.
Dale began her career in clinical research as a Clinical Research Associate (CRA) and held roles of increasing responsibility with four (4) pharma/biotech companies. She currently works as a Director, Global Clinical Operations for Takeda Pharmaceuticals and is located remotely in Baltimore-Washington metro area. She is responsible for hiring, training and development of Clinical Operations Managers (COMs) for management of global clinical trials.
She is a former non-profit board member of Women of Color in Pharma (WOCIP) where she was Director, Membership. She is also a current member of WOCIP, and Healthcare Businesswomen’s Association (HBA). She regularly attends Industry conferences and Summits to stay abreast of the constantly changing pharma/healthcare landscape.
The health disparities exposed during and in the aftermath of the COVID-19 pandemic coupled with Dale’s personal healthcare journey as a breast cancer survivor has fueled her passion for health equity and increasing diversity in clinical trials. She welcomes the opportunity to leverage this passion and her professional expertise to promote accelerated drug development. Dale believes that this is indeed possible with better collaboration with patients/caregivers, their communities, healthcare organizations, advocacy organizations, regulators, vendors, HCPs and other partners within the healthcare/research ecosystem.